ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV)

CUSIP: 004468500

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
-1,614,690
Put/Call ratio
7.2%
SEC-reported price per share
$2.94
Number of holders
79
Value change
-$6,062,639
Number of buys
31
Open additional details 1 more signal available
Number of sells
32
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
106,975,205

Security key

004468500

Report period

Q1 2026

Institutions

79

Top holders

10

Ownership snapshot

Top reported holders of ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
TPG GP A, LLC
Disclosed value leader
TPG GP A, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 13% 13D/G row: TPG GP A, LLC Showing 1-6 of 15 holder rows.

Quick read

TPG GP A, LLC leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TPG GP A, LLC's linked filing trail.
Comparable ownership Top 5
TPG GP A, LLC 13%
Alyeska Investment Group, L.P. 5.6%
VANGUARD GROUP INC 5%
Contrarian Alpha, LP 4.9%
FRANKLIN RESOURCES INC 4.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
TPG GP A, LLC
13D/G
13%
$40,440,170
13,755,160 shares
$0 17 Apr 2025
Alyeska Investment Group, L.P.
13D/G
5.6%
$9,395,574
2,982,722 shares
-$6,098,715 30 Sep 2025
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group
5%
from 13D/G
$12,297,331
2,474,312 shares
31 Dec 2025
Contrarian Alpha, LP
13D/G
Parker Quillen
4.9%
$7,964,388
2,528,377 shares
$0 30 Sep 2025
FRANKLIN RESOURCES INC
13F
Company
13F
4.1%
$21,714,889
4,369,193 shares
31 Dec 2025
Propel Bio Management, LLC
13F
Company
13F
3.5%
$18,818,532
3,786,425 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
79
Shares
21,523,954
Rows available
79
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
79
Q1 2026 holders
79
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .